• Slider home

IRBM

About us

IRBM Research and Development

The privately owned IRBM Group, a diversified industrial group operating within the biotech and pharmaceutical sector, is composed by IRBM, PROMIDIS, Advent and the CNCCS Consortium. IRBM is the parent company dedicated to innovative preclinical drug discovery and development in areas of high unmet medical need, including neurodegenerative and rare and neglected diseases.

 Delivering value to preclinical drug discovery and development partnerships. Our team of experienced scientists has a proven track record. 

Areas of particular expertise include fully integrated small molecule and peptide-based drug discovery, peptide-based vaccines, ADMET optimization and biomarker development.

In particular we relish the challenge of poorly druggable targets.

IRBM Brochure | Download

BIO International Convention 2015

03-03-2015

We are present at the BIO International Convention, June 16-18 2015, Philadelphia, Pennsylvania.

EU & National Projects

03-02-2014

Click here to learn more about our EU and National Projects!

IRBM Partner CNR ISS CNCCS

Questo sito utilizza cookie, propri o di terze parti, per migliorare la tua esperienza di navigazione. Se vuoi saperne di più, consulta la cookie policy.
Chiudendo questo messaggio, proseguendo la navigazione o utilizzando il qualsiasi forma il sito, acconsenti all’uso dei cookie.